This is in line with existing evidence of especially tau pathology being associated with neurodegeneration [15, 62, 63], which also could also explain why CSF p-tau181 did not remain significant in the multivariate model, i.e. when taking atrophy into account, as tau pathology did not explain additional cognitive decline beyond atrophy. This evidence concerns the gene MAPT and Mental deterioration.